Trial: 201808057

A Phase 2 Study of Ibrutinib as Neoadjuvant Therapy in Patients with Localized Prostate Cancer

Phase

II

Principal Investigator

Pachynski, Russell

Disease Site

Prostate

Learn more about this study at: clinicaltrials.gov